We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

International Biotechnology Trust plc (IBT) Ordinary 25p Shares

Sell:696.00p Buy:714.00p 0 Change: 4.00p (0.56%)
Market closed Prices as at close on 16 August 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Change: 4.00p (0.56%)
Market closed Prices as at close on 16 August 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Change: 4.00p (0.56%)
Market closed Prices as at close on 16 August 2022 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Trade high:
Year high:
Estimated NAV:
Previous close:
Trade low:
Year low:
7.00p (1.00%)
Dividend yield:
Data delayed by at least 15 minutes.


  • Net Asset Value (NAV)
INT.BIOTECH. performance chart


INT.BIOTECH. performance chart
Full interactive share price and premium / discount charts


1 week 1W 0.85% 1 year 1Y 1.93%
1 month 1M 3.2% 2 years 2Y 4.18%
3 months 3M 15.45% 3 years 3Y 11.99%
6 months 6M 6.93% 5 years 5Y 19.73%

Performance figures are based on the previous close price. Past performance is not an indication of future performance.

Trust Basics

Benchmark: Nasdaq Biotechnology Index
Annual management charge: 0.9% of Net Assets
Performance fee: Yes
Ongoing charge: 1.30%
Dividend yield: 3.98%
Dividend frequency: Semi-Annually
Total assets: £314m
Gross gearing: 105%
Market capitalisation:Market cap.: £287m
Shares in issue: 40.86 million
Legal structure Closed Ended Investment Company
Domicile: United Kingdom
ISIN GB0004559349

Recent dividends paid or declared by International Biotechnology Trust plc:

Type Ex-div date Payment date Amount
2nd interim * 04/08/2022 26/08/2022 15.70p
1st interim 30/12/2021 28/01/2022 15.70p
2nd interim 15/07/2021 27/08/2021 14.20p
1st interim 24/12/2020 29/01/2021 14.20p
2nd interim 16/07/2020 28/08/2020 12.40p

* Dividend has not yet been paid but has been declared by International Biotechnology Trust plc.

This data is provided by Digital Look. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision.

Full dividend history

Five years' total annual International Biotechnology Trust plc dividends:

year end
Total dividend
31/08/2021 3.90% -0.24 28.40p
31/08/2020 3.40% -0.23 24.80p
31/08/2019 4.40% -0.20 28.00p
31/08/2018 4.00% -0.26 27.00p
31/08/2017 4.00% -0.20 23.00p

All dividend data is calculated excluding any special dividends. Historical dividends may be adjusted to reflect any subsequent rights issues and corporate actions.

Full dividend history

Ready to invest?

To buy shares in , you'll need to have an account.
Try our handy filter to explore the different options.

Compare accounts

Ready to invest?

To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.

Compare accounts

Important Documents


The objective is to achieve long term capital growth by investing in high growth, development stage biotechnology companies that are either quoted or unquoted. The company invests in companies that are considered to be good value with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.


Estimated NAV: 729.49
Latest actual NAV: 641.73
Latest actual NAV date: 22 February 2022
Premium/Discount: -3.63%
12m average Premium/Discount: -3.44%
NAV frequency: Daily

Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.

Security Weight
Neurocrine Biosciences Inc 6.75%
Horizon Therapeutics plc Ordinary Shares 6.72%
Incyte Corp 5.30%
Regeneron Pharmaceuticals Inc 4.11%
Seagen Inc Ordinary Shares 3.40%
Harmony Biosciences Holdings Inc Ordinary Shares 3.17%
Biogen Inc 3.11%
Amgen Inc 2.91%
Ultragenyx Pharmaceutical Inc 2.82%
Travere Therapeutics Inc Ordinary Shares 2.70%
Sector Weight
Healthcare 98.78%
Country Weight
United States 82.86%
China 4.18%
Netherlands 2.44%
Belgium 2.02%
Canada 1.92%
Switzerland 1.54%
Sweden 1.27%
Germany 1.13%
Denmark 0.54%
France 0.46%

Key Dates

Launch date: 31 March 1994
Financial year end: August
Next AGM: December 2022
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by NBTrader. Charts provided by Factset. Dividend data provided by Digital Look. Recent trade data provided by MoneyAM. Trust basics, holding data, key dates, objective and NAV provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.